Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (18): 2862-2866.doi: 10.3969/j.issn.2095-4344.2015.18.013

Previous Articles     Next Articles

Effect of Ginsenoside Rg1 on transformation growth factor-beta and brain-derived neurotrophic factor expression in spinal cord injury rats

Sun Jian-zhong1, 2, Liu Xin-wei3, Guan Hua-peng1, Zhang Peng1, Liu Qi1, Yang Jun1, Guo Qun-feng1, Ni Bin1   

  1. 1Department of Orthopedics, Changzheng Hospital, the Second Military Medical University of Chinese PLA, Shanghai 200003, China; 2Department of Orthopedics, Baoshan Hospital of Integrated Medicine, Shanghai 201900, China; 3Department of Orthopedics, General Hospital of Shenyang Military Area Command of Chinese PLA, Rescue Center of Severe Wound and Trauma of Chinese PLA, Shenyang 110016, Liaoning Province, China
  • Received:2015-02-06 Online:2015-04-30 Published:2015-04-30
  • Contact: Ni Bin, M.D., Professor, Chief physician, Doctoral supervisor, Department of Orthopedics, Changzheng Hospital, the Second Military Medical University of Chinese PLA, Shanghai 200003, China
  • About author:Sun Jian-zhong, Studying for doctorate, Attending physician, Department of Orthopedics, Changzheng Hospital, the Second Military Medical University of Chinese PLA, Shanghai 200003, China; Department of Orthopedics, Baoshan Hospital of Integrated Medicine, Shanghai 201900, China
  • Supported by:

    Young Medical Talents Cultivation Plan of Baoshan District of Shanghai, No. bswsyq-2014-A03; the grant from Baoshon Hospital of Integrated Medicine, No. 201502

Abstract:

BACKGROUND: Transformation growth factor-β (TGF-β) and brain-derived neurotrophic factor (BDNF) are the main regulatory factors in the process of spinal cord injury. There are many researches for TGF-β and BDNF pathogenesis in the spinal cord injury, but the regulation of Ginsenoside Rg1 intervention on TGF-β and BDNF in the spinal cord injury is rarely reported.
OBJECTIVE: To observe the effect of Ginsenoside Rg1 intervention on TGF-β and BDNF expression at the molecular protein levels, and to study the protection effect of Ginsenoside Rg1 on the spinal cord and nerve function after spinal cord injury.
METHODS: Experimental rats were randomly divided into blank control group, model group and Ginsenoside Rg1 group. In the model and Ginsenoside Rg1 groups, spinal cord injury model was established with the impact method in rats. In the Ginsenoside Rg1 group, rats were intraperitoneally injected with 10 mg/kg Ginsenoside Rg1 24 hours after modeling, once per day, for 14 days. Rats in the blank control and model groups were injected with equal saline.
RESULTS AND CONCLUSION: Compared with the control group, serum malondialdehyde levels increased, the content of superoxide dismutase decreased, TGF-β expression levels in spinal cord tissue increased, and BDNF expression levels decreased in the model and Ginsenoside Rg1 groups. Compared with the model group, serum malondialdehyde levels decreased, the content of superoxide dismutase increased, TGF-β expression levels in spinal cord tissue decreased, and BDNF expression levels increased in the Ginsenoside Rg1 group. Ginsenoside Rg1 can protect the injury spinal cord in rats after spinal cord injury.



中国组织工程研究
杂志出版内容重点:肾移植肝移植移植;心脏移植;组织移植;皮肤移植;皮瓣移植;血管移植;器官移植组织工程


全文链接:

Key words: Ginsenosides, Spinal Cord Injury, Oxidoreductases, Neurturin

CLC Number: